UNSPSC 51281602: Spectinomycin

This classification denotes an aminoglycoside antibiotic with the molecular formula C14H24N2O7, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier 93AKI1U6QF, chemically known as 4h-pyrano(2,3-b)(1,4)benzodioxin-4-one, decahydro-4a,7,9-trihydroxy-2-methyl-6,8-bis(methylamino)- but generally known as spectinomycin, which bears US NIH Compound Identifier 2021. European Medicines Agency schedules Spectinomycin in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB10614MIG.

UNSPSC 51281602 Spectinomycin is a Commodity code that nominally names a specific antibiotic product, but recent state and local procurement activity under this code does not center on spectinomycin procurement. Instead, the opportunities tagged to this code reflect a broader pharmaceutical and medical supply sourcing landscape driven by public health agencies, emergency response services, and state health benefit programs seeking to procure generic pharmaceuticals, naloxone, medical supplies, and pharmacy benefit solutions through cooperative purchasing arrangements and competitive sealed bidding.

State and local issuing bodies under this code include county health departments (Seminole County, Florida), city fire and rescue divisions (City of Tampa), state health and human services commissions (Texas HHS Commission), and multistate cooperative purchasing alliances (Minnesota Multistate Cooperative Purchasing Alliance serving state and local government facilities across multiple states including Oregon). The mix reflects both direct procurement by local jurisdictions and participation in cooperative purchasing vehicles that aggregate demand across member states and localities. The most recent activity spans Florida, Texas, and Minnesota, with broader multistate participation through MMCAP. Representative recent opportunities include Seminole County's IFB for naloxone and drug deactivation systems (1,900 units naloxone and 800 deactivation systems annually, response due July 26, 2023, though the posting date of June 30, 2026 suggests a date discrepancy in the source); the City of Tampa's IFB for medical and first aid supplies to the Fire Department Rescue Division (169 line items, estimated contract value $700,000, sheltered for certified Small Local Business Enterprises with a 5 percent bid discount not to exceed $10,000, response due March 13, 2026); Minnesota's MMCAP RFP for generic multi-source pharmaceuticals and OTC products distributed through authorized wholesalers (proposals due March 26, 2026, contract effective July 1, 2026); and the Texas HHS Commission's RFI on direct-to-manufacturer prescription programs (response due April 3, 2026, exploratory phase informing future formal procurement).